What 5 Analyst Ratings Have To Say About NuVasive
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on NuVasive (NASDAQ:NUVA) stock, with 3 somewhat bullish and 2 indifferent. The company has an average 12-month price target of $51.0, which has increased by 8.9% over the past month.
May 31, 2023 | 3:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
NuVasive (NASDAQ:NUVA) received 3 somewhat bullish and 2 indifferent ratings from 5 analysts over the past 3 months. The average 12-month price target is $51.0, up 8.9% in the past month.
The 5 analysts' opinions on NuVasive stock are mostly positive, with 3 somewhat bullish and 2 indifferent ratings. The average 12-month price target has increased by 8.9% over the past month, indicating a positive outlook for the stock in the short term. This could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100